Navigation Links
YM BIOSCIENCES REPORTS 2007 YEAR END OPERATIONAL AND FINANCIAL RESULTS
Date:9/23/2007

-----------

Basic and

diluted loss

per common

share $ (0.57) $ (0.59) $ (0.47)

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Weighted

average

number of

common

shares

outstanding 55,804,674 43,755,160 34,046,450

Excludes

common shares

held in

escrow for

contingent

additional

payment

related to

the

acquisition

of Delex

Therapeutics

Inc. 2,380,953 2,380,953 2,777,778

-------------------------------------------------------------------------

-------------------------------------------------------------------------

YM BIOSCIENCES INC.

(A DEVELOPMENT STAGE COMPANY)

Consolidated Statements of Cash Flows

(Amounts in Canadian dollars, unless otherwise noted)

-------------------------------------------------------------------------

Period from

inception on

August 17,

1994

Years ended June 30, to June 30,

2007 2006 2005 2007

-------------------------------------------------------------------------

Cash provided

by (used in):

Operating

activities:

Loss for the

period $ (31,730,240) $ (25,814,607) $ (15,859,295) $(117,506,608)

Items not

involving

cash:

Deprecia-

tion of

property

and

equipment 107,
'/>"/>

SOURCE YM BioSciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Perscitus Biosciences secures $250K Commerce loan
2. Wisconsin biosciences rise to the challenge
3. Quintessence Biosciences advances cancer drug
4. Quintessence Biosciences names new president
5. Caden Biosciences may signal critical mass
6. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
7. WARF signs licensing pact with BD Biosciences
8. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
9. State awards QRG Biosciences development grant
10. EMD Biosciences partners with European biotech company
11. Quintessence Biosciences forms cancer therapeutic advisory board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... IRVING, Texas , May 29, 2015 /PRNewswire/ ... company focused on fulfilling the promise of precision ... five studies that demonstrate the clinical utility of ... comprehensive tumor profiling service, in helping to identify ... aggressive tumors. In each of the studies, results ...
(Date:5/29/2015)... Translation is frequently listed as one of ... reason--if used in a way that is right for a ... business product or service offering. , Here are some ... effect on a company's bottom line: , 1.    Attract bigger audience. ... world can use, why not offer it globally? Nelson Mandela ...
(Date:5/28/2015)... , May 27, 2015 ... the addition of Jain PharmaBiotech,s new report ... to their offering. An increasing ... biotechnology industries is anticipated. Nanotechnology will be ... - from formulations for optimal delivery to ...
(Date:5/28/2015)... Celsion Corporation (the "Company") (NASDAQ: CLSN ... two institutional healthcare investors to purchase an aggregate of ... an at-the-market registered direct offering and a concurrent private ... The Company entered into a definitive purchase agreement with ... sell an aggregate of 3,000,000 shares of its common ...
Breaking Biology Technology:Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 2Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 3Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 4Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 5Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 6Three Ways Translation Can Help Businesses Grow 2Global Nanobiotechnology Market 2015-2024 - Applications, Markets and Companies 2Global Nanobiotechnology Market 2015-2024 - Applications, Markets and Companies 3Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering 3
... KNDL ), a,leading, global full-service clinical research organization, ... PharmD, and,President and Chief Operating Officer Chris Bergen ... the company,s common stock over,a designated period. The ... long-term strategy for tax planning and asset diversification ...
... best treatment ... heart disease, BIRMINGHAM, Ala., March 7 Atherotech, Inc., ... Test(R) in Booth 21041 at the American College of Cardiology,(ACC) ... 29-April 1, 2008, at the McCormick Place Convention Center in,Chicago, ...
... (NYSE: ABT ),will present at the Cowen and ... 2008. Thomas C. Freyman, executive vice president,finance and chief ... at 10:30 a.m. Central time., A live audio ... Relations Web site at http://www.abbottinvestor.com . An,archived edition ...
Cached Biology Technology:Kendle Leaders Adopt 10b5-1 Trading Plans 2Atherotech to Exhibit the VAP Test (R) at ACC 2008 Meeting in Chicago 2
(Date:5/25/2015)...  Australia,s market for wearable technologies is considered to ... advent of several trials and prototypes. The release of ... to ignite interest in wearables as well as accelerate ... . This in turn will spur greater innovation from ... amongst vendors and distributors. Photo - ...
(Date:5/21/2015)... 21, 2015 According to ... Solutions (Hardware, Software, Services), by Applications (Surveillance (Airborne, ... by End-Users (Military & Defense & Commercial) - ... Imaging Market is expected to grow from $7252.0 ... at a Compound Annual Growth Rate (CAGR) of ...
(Date:5/20/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... LLC, a company engaged in biometric identification is an ... portion of the recently awarded TIES (Technical Information Engineering ... Army. 3D-ID LLC has a suite of ... and security agencies. Gino Pereira , ...
Breaking Biology News(10 mins):Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3
... 14-year study by the Wildlife Conservation Society in an ... that fishing closures there produce encouraging increases in populations ... in only minimal increases in herbivorous fish, which feed ... recovery. The findings will help WCS researchers ...
... Any diver returning from ocean depths knows about the hazard of ... the ocean pressure decreases, gases that were absorbed by the body ... is too rapid, can cause bubbles to form in the body. ... pain and rashes to paralysis and death. , But how do ...
... University of Miami biology professor Akira Chiba is ... survey of protein interactions within brain cells. The team ... networks (isPIN) within the neurons of a multicellular organism. ... Cell Biology annual meeting, December 3 through 7, 2011, ...
Cached Biology News:Belize protected area boosting predatory fish populations 2Belize protected area boosting predatory fish populations 3Study examines how diving marine mammals manage decompression 2How the brain cell works: A dive into its inner network 2
...
...
...
... Sheep polyclonal to Decorin ( ... Antigen: Synthetic ... to amino acids 6-19 of Human ... molecule bone proteoglycan II). ...
Biology Products: